Vivos Therapeutics GAAP EPS of -$0.07 beats by $0.25, revenue of $6.41M beats by $0.94M
- Vivos Therapeutics press release (VVOS): Q3 GAAP EPS of -$0.07 beats by $0.25.
- Revenue of $6.41M (-5.5% Y/Y) beats by $0.94M.
Recommended For You
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Black Friday: Create a Free Seeking Alpha Account
See what's moving the market with unlimited news access, and get 20% off your first year of any Seeking Alpha service.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.